Methylprednisolone Acetate (Injection) Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 40 mg/mL, 80 mg/mL, 125 mg/2 mL
Reference Brands: Depo-Medrol(US)
Category:
Arthritis
Methylprednisolone acetate injection is a corticosteroid that suppresses inflammation by reducing immune response and inflammatory gene expression. It provides rapid relief for severe flare-ups, joint pain, and swelling. Benefits include targeted, fast-acting anti-inflammatory effects, improved joint mobility, and effective long-term disease management when used under medical supervision.
Methylprednisolone Acetate (Injection) is available in Injection
and strengths such as 40 mg/mL, 80 mg/mL, 125 mg/2 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Methylprednisolone Acetate (Injection) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Methylprednisolone Acetate (Injection) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Methylprednisolone acetate injection is approved in the EU and US for severe inflammatory and autoimmune conditions. In the EU, brands like Solu-Medrol are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on extensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for approval and continuous pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We streamline global market access for methylprednisolone acetate injections, ensuring adherence to European and American standards for safe, effective corticosteroid therapy, helping you navigate complex regulatory landscapes seamlessly.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing